These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of association between an ecNOS gene polymorphism and diabetic nephropathy in type 2 diabetic patients with proliferative diabetic retinopathy. Fujita H, Narita T, Meguro H, Ishii T, Hanyu O, Suzuki K, Kamoi K, Ito S. Horm Metab Res; 2000 Feb; 32(2):80-3. PubMed ID: 10741691 [Abstract] [Full Text] [Related]
4. Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Neugebauer S, Baba T, Watanabe T. Diabetes; 2000 Mar; 49(3):500-3. PubMed ID: 10868974 [Abstract] [Full Text] [Related]
7. [The association between polymorphism of endothelial nitric oxide synthase gene and diabetic nephropathy]. Li C, Dong Y, Lü W. Zhonghua Nei Ke Za Zhi; 2001 Nov; 40(11):729-32. PubMed ID: 11930675 [Abstract] [Full Text] [Related]
13. Endothelial function and carotid intima-media thickness in young healthy subjects among endothelial nitric oxide synthase Glu298-->Asp and T-786-->C polymorphisms. Paradossi U, Ciofini E, Clerico A, Botto N, Biagini A, Colombo MG. Stroke; 2004 Jun; 35(6):1305-9. PubMed ID: 15073390 [Abstract] [Full Text] [Related]
14. Haptoglobin genotype and diabetic microangiopathies in Japanese diabetic patients. Koda Y, Soejima M, Yamagishi S, Amano S, Okamoto T, Inagaki Y, Yamada K, Kimura H. Diabetologia; 2002 Jul; 45(7):1039-40. PubMed ID: 12187922 [No Abstract] [Full Text] [Related]
20. A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ. Circulation; 1999 Oct 05; 100(14):1515-20. PubMed ID: 10510054 [Abstract] [Full Text] [Related] Page: [Next] [New Search]